Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?

Olmez, O. F.Bilici, A.Gursoy, P.Cubukcu, E.Yildiz, O.Sakin, A.Korkmaz, T.Cil, I.Cakar, B.Menekse, S.Demir, T.Acikgoz, O.Hamdard, J.2023-02-212023-02-212019-01-0110.1016/j.jtho.2019.08.1152https://hdl.handle.net/11443/2617http://dx.doi.org/10.1016/j.jtho.2019.08.1152Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?ArticleWOS:000492162203068